showed a trendp=0.051
However, the tumor grade group G2 + G3 showed a trend towards worse OS compared to G1 (HR=2.386, 95% CI 0.994-5.727, p=0.051).
However, the tumor grade group G2 + G3 showed a trend towards worse OS compared to G1 (HR=2.386, 95% CI 0.994-5.727, p=0.051).
In the CAD cohort with a 2-year follow up, LDL-C levels measured within the last 3 months of follow up were significantly associated with an increased risk of BARC criteria 3 to 5 grade bleeding (P < 0.001) and showed a trend toward an increased risk of ICH (P = 0.051).
Interestingly, CRTC1 mRNA expression showed a trend to be inversely correlated with Prom1 methylation levels (r Spearman = −0.949, p = 0.051) in the control group; meanwhile, no significant correlation was found between methylation and expression among AD patients (r Spearman = −0.287, p = 0.490). mRNA levels of CRTC1 downstream target genes are altered in Alzheimer’s disease hippocampus We also wanted to test whether CRTC1 -dependent genes were also dysregulated in our set of AD hippocampal samples.
Firstly, expression levels of Dnmt3a showed a trend toward an increase in GBH- and Gly-exposed groups in relation to control group ( Figure 5B ; p = 0.0510), while there was no difference when comparing the exposed groups.
The studies with patients receiving immunotherapy as a second-line treatment or beyond showed a trend towards a significant overall effect (HR = 1.38; p = 0.051) ( Figure S1B ); heterogeneity was high in these studies (Chi 2 = 39.48; p < 0.001; I 2 = 80%). 3.6.
Darker-skinned individuals were higher in colour saturation (fair-skinned 33.83 + / − 0.85, dark-skinned: 37.76 + / − 2.83, t = 5.92, df = 10, p < .001, d = 2.53) and showed a trend to be lower in colour value (fair-skinned 74.87 + / − 1.75, dark-skinned: 73.37 + / − 2.46, t = 2.25, df = 10, p = .051, d = 0.64).
Three-back accuracy was significantly improved in individuals with EOS ( Z = −2.157, p = 0.031), whereas typically developing adolescents showed a trend of accuracy improvement ( Z = −1.949, p = 0.051) ( Table 1 ).
Nevertheless, patients with high‐risk cytogenetics showed a trend toward lower 3‐year PFS than those without (77.8% vs. 89.4%, p = 0.051), and ultra‐high‐risk cytogenetics (≥2 high‐risk cytogenetics) had an even worse prognosis, with 61.2% 3‐year PFS.
Log TILL showed a trend to be higher in the amnestic VCI group versus normal cognition (mean difference 0.709, 95% CI −0.003–1.421, SE 0.2995, P = 0.051).
Preoperative propranolol use showed a trend towards a higher risk of CVE (OR 1.66, 95% CI 1.00–2.77, p = 0.051).
The addition of the PML showed a trend of increase in Akkermansia population compared to LN group ( P = 0.051).
The overall improvement of ODI and SRS-30 compared to baseline was similar in both groups (all p > 0.05), however the ERF group showed a trend toward lower improvement of ODI at 1-year postoperatively (17.3 vs 24.6, p = 0.051).
Among 48 patients receiving 3L therapy, regorafenib showed a trend toward improved OS over sorafenib (HR, 0.33; 95% CI, 0.11 to 1.02; p=0.051), supported by restricted mean survival time analysis (p=0.028).
Disease status at CAR T-cell infusion showed a trend toward inferior PFS (HR, 1.58; P = .051).
A comparison between the ECP groups showed a trend towards lower CK in the HTK group at six hours after replantation ( p = 0.051) but comparable CK levels at 12 h ( p = 0.095).
For tumor size, pT2 compared with pT1 showed a significant association (hazard ratio 2.39, 95% CI 1.15–13.0, p = 0.028), while pT3 compared with pT1 showed a trend toward an association (hazard ratio 2.45, 95% CI 1.00–13.6, p = 0.051).
Under control conditions (1000 s stimulation pause), waveforms in CA3a showed a trend towards increased diversity over time (median distances late/early recording period 1.08, p = 0.051, n = 11 data sets from 6 slices), which reached significance in CA3b (median 1.14, p = 0.016, n = 17 data sets from 9 slices).
NASA-TLX scores remained unchanged, but SURG-TLX showed a trend toward higher mental demand ( p = 0.051) and a significant increase in distraction ( p = 0.014).
When compared to MCS, controls only showed a trend towards higher theta PLI at electrode Cz ( T 29 = 2.04, p = .051).
For the traditional section, however, the only significant predictors were prior GPA and ethnicity (note type was not analyzed for this section), although class standing showed a trend ( p = 0.073), and major had borderline significance ( p = 0.051).
Moreover, the proportion of detected spines in MEC with filopodial morphology was negatively correlated with SD interventions required ( Figure 3 , bottom; Pearson’s r = −0.94, p < .05), while the proportion with stubby morphology showed a trend for positive correlation with SD interventions (Pearson’s r = 0.88, p = .051).
Univariate analysis for overall survival revealed that those patients at the S 2–3 stage and those receiving second-line therapies showed a trend of having an increased death risk (hazard ratio [HR] = 8.26, 95% confidence interval (CI), 0.99-68.67, p = 0.051; HR = 7.76, 95% CI, 0.93-64.99, p = 0.059, respectively).
Further experiments using a small interfering RNA (siRNA)-mediated knockdown approach also showed a trend toward reduced SOX9 mRNA levels in PGR siRNA-treated hGLCs ( p = 0.051), consistent with PGR-dependent control of SOX9 transcription ( Figure S2 B).
5571 ± 3524 ms 2 /Hz, p = 0.002) and showed a trend toward higher values during SSM (58,941 ± 91,929 ms 2 /Hz, p = 0.051).
The overall scalp oscillation cluster pattern showed a trend toward statistical significance, with an OR of 4.81 (95% CI: 0.99–23.32; p = 0.051; Table 4 ).